BioCryst制药(BCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BCRX BioCryst制药

盘前交易 05-10 05:24:55 EDT

5.34

+0.24

+4.71%

最高5.35	最低5.06	成交量335.52万
今开5.14	昨收5.10	日振幅5.69%
总市值11.02亿	流通市值10.22亿	总股本2.06亿
成交额1,770万	换手率1.75%	流通股本1.91亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BCRX","market":"US","secType":"STK","nameCN":"BioCryst制药","latestPrice":5.34,"timestamp":1715284800000,"preClose":5.1,"halted":0,"volume":3355204,"delay":0,"floatShares":191423623,"shares":206377088,"eps":-1.062062,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.24,"latestTime":"05-10 05:24:55 EDT","open":5.14,"high":5.35,"low":5.06,"amount":17701368.48718,"amplitude":0.056863,"askPrice":6.29,"askSize":100,"bidPrice":4.89,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.062062,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715347800000},"adr":0,"listingDate":762670800000,"adjPreClose":5.34,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":5.71,"preClose":5.34,"latestTime":"19:59 EDT","volume":227523,"amount":1220159.2969,"timestamp":1715299188327},"volumeRatio":0.6943840191897982},"requestUrl":"/m/hq/s/BCRX/wiki","defaultTab":"wiki","newsList":[{"id":"2433841037","title":"摩根大通证券公司：维持BioCryst Pharma(BCRX.US)评级，由优于大市调整至优于大市评级, 目标价由14.00美元调整至15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433841037","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433841037?lang=zh_cn&edition=full","pubTime":"2024-05-07 23:34","pubTimestamp":1715096073,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：维持BioCryst Pharma(BCRX.US)评级，由优于大市调整至优于大市评级, 目标价由14.00美元调整至15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072334358ae56695&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072334358ae56695&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433788579","title":"BioCryst制药盘中异动 早盘股价大涨5.12%报5.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433788579","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433788579?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:31","pubTimestamp":1715088680,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日21时31分，BioCryst制药股票出现异动，股价大幅上涨5.12%。截至发稿，该股报5.54美元/股，成交量21.1113万股，换手率0.10%，振幅2.85%。BioCryst制药股票所在的生物技术行业中，整体涨幅为0.74%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。该信息摘要如下：HC Wainwright & Co.：重申BioCryst Pharma评级，由买入调整至买入评级, 目标价30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072131217a588547&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072131217a588547&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433727590","title":"HC Wainwright & Co.：重申BioCryst Pharma(BCRX.US)评级，由买入调整至买入评级, 目标价30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433727590","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433727590?lang=zh_cn&edition=full","pubTime":"2024-05-07 18:26","pubTimestamp":1715077570,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申BioCryst Pharma(BCRX.US)评级，由买入调整至买入评级, 目标价30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050718261287dc18cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050718261287dc18cb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433724078","title":"美国研究综述-ServiceNow、Ulta Beauty、Vertex Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2433724078","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433724078?lang=zh_cn&edition=full","pubTime":"2024-05-07 16:20","pubTimestamp":1715070052,"startTime":"0","endTime":"0","summary":"    路透5月7日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 ServiceNow、Ulta Beauty 和 Vertex Pharmaceuticals。要闻  * 艾睿电子  ：雷蒙德-詹姆斯将目标价从130美元上调至135美元 * Cardinal Health Inc   ：杰富瑞将目标价从110美元下调至105美元 * ServiceNow Inc   ：贝雅将目标价从870美元上调至885美元 * Ulta Beauty Inc   ：奥本海默将目标价从500美元下调至475美元 * Vertex Pharmaceuticals Inc   ：Piper Sandler将目标价从450美元上调至456美元 以下是路透周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433295494","title":"BioCryst因肿胀障碍治疗产品销售强劲而攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2433295494","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433295494?lang=zh_cn&edition=full","pubTime":"2024-05-06 19:26","pubTimestamp":1714994776,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    5月6日 - ** 制药商 BioCryst Pharmaceuticals    的股价盘前上涨 ~7.4% 至 4.78 美元* (link) * 由于遗传性血管性水肿治疗药物Orladeyo销售强劲，该公司第一季度营收为9280万美元，高于分析师平均预期的8560万美元 - LSEG数据** 遗传性血管性水肿是一种以反复发作的严重肿胀为特征的疾病。 ** 截至上次收盘，股价累计下跌 25.7","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432907124","title":"BioCryst Pharmaceuticals Inc    预计每股亏损 21 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432907124","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432907124?lang=zh_cn&edition=full","pubTime":"2024-05-03 23:47","pubTimestamp":1714751232,"startTime":"0","endTime":"0","summary":"   * BioCryst Pharmaceuticals Inc    将于5月6日公布截至2024年3月31日的财报，预计该公司的季度收入将有所增长。* LSEG 分析师对 BioCryst Pharmaceuticals Inc 的平均预期是每股亏损 21 美分。* 华尔街对 BioCryst Pharmaceuticals Inc 的 12 个月目标价中位数为 11.00 美元，高于其上次收盘价 4.48 美元。5月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432701765","title":"BioCryst制药盘中异动 早盘股价大涨5.21%报4.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432701765","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432701765?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:37","pubTimestamp":1714570665,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时37分，BioCryst制药股票出现波动，股价大幅拉升5.21%。截至发稿，该股报4.35美元/股，成交量39.2098万股，换手率0.19%，振幅4.35%。BioCryst制药股票所在的生物技术行业中，整体涨幅为0.52%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050121374587e852b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050121374587e852b9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428660157","title":"BioCryst制药盘中异动 下午盘股价大跌5.00%报4.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428660157","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428660157?lang=zh_cn&edition=full","pubTime":"2024-04-20 02:26","pubTimestamp":1713551180,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日02时26分，BioCryst制药股票出现波动，股价急速跳水5.00%。截至发稿，该股报4.28美元/股，成交量223.47万股，换手率1.08%，振幅6.78%。BioCryst制药股票所在的生物技术行业中，整体跌幅为0.04%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042002262087e822fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042002262087e822fb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427982606","title":"BUZZ-美国医疗保险公司因 UnitedHealth 第一季度利润增长而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2427982606","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2427982606?lang=zh_cn&edition=full","pubTime":"2024-04-16 20:25","pubTimestamp":1713270314,"startTime":"0","endTime":"0","summary":"    4月16日 - ** 联合健康集团  公布第一季度财报后，美国医疗保险公司股价在盘前交易中上涨2%至5%。** 尽管其 Change Healthcare 部门 2 月份遭受的网络攻击造成了干扰，但 UNH 仍公布了  乐观的第一季度副利润，并维持 2024 年的业绩预期。** 竞争对手 Humana   上涨 4.6%，CVS Health   上涨 3.8%，Cigna Group   上涨 2.1** 自 11 月下旬以来，医疗保险公司的股价一直承压，当时 UNH 表示，老年人医疗保健的年末增长导致了医疗成本的上升。** 截至目前，HUM 下跌 31.3%，CVS 下跌 12.7%，UNH 下跌 15.4%，而 CI 则上涨 16.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426299115","title":"BioCryst制药盘中异动 下午盘大幅拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426299115","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426299115?lang=zh_cn&edition=full","pubTime":"2024-04-12 02:31","pubTimestamp":1712860268,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日02时31分，BioCryst制药股票出现波动，股价快速拉升5.03%。BioCryst制药股票所在的生物技术行业中，整体跌幅为0.07%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。该信息摘要如下：Needham：重申BioCryst Pharma评级，由买入调整至买入评级, 目标价12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120231087a5231e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120231087a5231e4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426408494","title":"BioCryst制药盘中异动 快速下挫5.00%报4.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426408494","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426408494?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:43","pubTimestamp":1712756581,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时43分，BioCryst制药股票出现异动，股价急速跳水5.00%。截至发稿，该股报4.56美元/股，成交量11.2751万股，换手率0.05%，振幅2.60%。BioCryst制药股票所在的生物技术行业中，整体跌幅为1.53%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。该信息摘要如下：Needham：重申BioCryst Pharma评级，由买入调整至买入评级, 目标价12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021430187e7f4c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021430187e7f4c9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426906464","title":"Needham：重申BioCryst Pharma(BCRX.US)评级，由买入调整至买入评级, 目标价12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426906464","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426906464?lang=zh_cn&edition=full","pubTime":"2024-04-10 19:16","pubTimestamp":1712747763,"startTime":"0","endTime":"0","summary":"Needham：重申BioCryst Pharma(BCRX.US)评级，由买入调整至买入评级, 目标价12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101916068b09cd39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101916068b09cd39&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424025196","title":"BioCryst制药盘中异动 急速下跌5.05%报4.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424025196","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424025196?lang=zh_cn&edition=full","pubTime":"2024-04-03 00:04","pubTimestamp":1712073843,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日00时04分，BioCryst制药股票出现波动，股价急速跳水5.05%。截至发稿，该股报4.80美元/股，成交量81.5301万股，换手率0.40%，振幅4.26%。BioCryst制药股票所在的生物技术行业中，整体跌幅为1.77%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404030004047a50ba62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404030004047a50ba62&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421084355","title":"BioCryst制药盘中异动 急速下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421084355","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421084355?lang=zh_cn&edition=full","pubTime":"2024-03-22 23:12","pubTimestamp":1711120330,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日23时12分，BioCryst制药股票出现异动，股价快速下挫5.10%。截至发稿，该股报5.21美元/股，成交量51.999万股，换手率0.25%，振幅5.28%。BioCryst制药股票所在的生物技术行业中，整体跌幅为0.13%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322231210861e0799&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322231210861e0799&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421046979","title":"BioCryst制药盘中异动 股价大涨5.12%报5.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421046979","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421046979?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:39","pubTimestamp":1711028399,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时39分，BioCryst制药股票出现波动，股价大幅上涨5.12%。截至发稿，该股报5.75美元/股，成交量18.4623万股，换手率0.09%，振幅4.94%。BioCryst制药股票所在的生物技术行业中，整体涨幅为0.53%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212139597a4e40cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212139597a4e40cf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420300270","title":"BioCryst制药盘中异动 股价大涨5.13%报5.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420300270","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420300270?lang=zh_cn&edition=full","pubTime":"2024-03-20 00:41","pubTimestamp":1710866463,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日00时41分，BioCryst制药股票出现波动，股价快速拉升5.13%。截至发稿，该股报5.33美元/股，成交量89.0784万股，换手率0.43%，振幅5.33%。BioCryst制药股票所在的生物技术行业中，整体跌幅为0.14%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320004103861df759&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320004103861df759&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419980645","title":"BioCryst制药盘中异动 大幅下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419980645","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419980645?lang=zh_cn&edition=full","pubTime":"2024-03-15 01:05","pubTimestamp":1710435937,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日01时05分，BioCryst制药股票出现波动，股价急速跳水5.06%。截至发稿，该股报4.88美元/股，成交量125.492万股，换手率0.61%，振幅4.09%。BioCryst制药股票所在的生物技术行业中，整体跌幅为0.59%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031501053787e78fe0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031501053787e78fe0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417239063","title":"BioCryst制药盘中异动 股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417239063","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417239063?lang=zh_cn&edition=full","pubTime":"2024-03-08 23:15","pubTimestamp":1709910921,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日23时15分，BioCryst制药股票出现异动，股价快速上涨5.41%。截至发稿，该股报5.46美元/股，成交量31.2953万股，换手率0.15%，振幅3.96%。BioCryst制药股票所在的生物技术行业中，整体跌幅为0.48%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，目的是阻断感染性和炎症性疾病中涉及的关键酶。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030823152287e77585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030823152287e77585&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416623131","title":"BioCryst制药2023财年实现净利润-2.27亿美元，同比增加8.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416623131","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416623131?lang=zh_cn&edition=full","pubTime":"2024-03-02 00:22","pubTimestamp":1709310166,"startTime":"0","endTime":"0","summary":"12月31日，BioCryst制药公布财报，公告显示公司2023财年净利润为-2.27亿美元，同比增加8.10%；其中营业收入为3.31亿美元，同比增加22.14%，每股基本收益为-1.18美元。从资产负债表来看，BioCryst制药总负债9.72亿美元，其中短期债务26.21百万美元，资产负债比为0.54，流动比率为3.31。机构评级：截至2023年12月31日，当前有10家机构对BioCryst制药目标价做出预测，其中目标均价为14.20美元，其中最低目标价为6.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030200225887d85b15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030200225887d85b15&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biocryst.com","stockEarnings":[{"period":"1week","weight":0.192},{"period":"1month","weight":0.1125},{"period":"3month","weight":-0.0872},{"period":"6month","weight":0.0723},{"period":"1year","weight":-0.3812},{"period":"ytd","weight":-0.1085}],"compareEarnings":[{"period":"1week","weight":0.03},{"period":"1month","weight":0.0016},{"period":"3month","weight":0.0378},{"period":"6month","weight":0.1806},{"period":"1year","weight":0.2599},{"period":"ytd","weight":0.0944}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BioCryst Pharmaceuticals, Inc.是一家生物技术公司，致力于设计、优化和开发新的药物，新的药物主要是阻止疾病的发病机制的关键酶。该公司是一家始建于1986年的特拉华州公司，该公司专注于治疗领域有未满足的医疗需求，并将其能力与专长联系在一起。公司的利益区域和候选药物的相关开发是由科学发现和潜在的优势，其经验丰富的药物研发组标识，以及这些发现内潜在的商业机会来决定的。该公司通过名为结构导向药物设计过程整合生物学，晶体学，药物化学和计算机模拟等学科，发现和开发小分子药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.566667,"avgChangeRate":0.030527},{"month":2,"riseRate":0.5,"avgChangeRate":-0.014169},{"month":3,"riseRate":0.366667,"avgChangeRate":0.019768},{"month":4,"riseRate":0.548387,"avgChangeRate":0.044665},{"month":5,"riseRate":0.548387,"avgChangeRate":0.049303},{"month":6,"riseRate":0.633333,"avgChangeRate":0.036002},{"month":7,"riseRate":0.566667,"avgChangeRate":0.117871},{"month":8,"riseRate":0.566667,"avgChangeRate":0.099165},{"month":9,"riseRate":0.366667,"avgChangeRate":-0.045723},{"month":10,"riseRate":0.5,"avgChangeRate":-0.050698},{"month":11,"riseRate":0.5,"avgChangeRate":0.042837},{"month":12,"riseRate":0.466667,"avgChangeRate":0.002044}],"exchange":"NASDAQ","name":"BioCryst制药","nameEN":"Biocryst Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioCryst制药(BCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioCryst制药(BCRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioCryst制药,BCRX,BioCryst制药股票,BioCryst制药股票老虎,BioCryst制药股票老虎国际,BioCryst制药行情,BioCryst制药股票行情,BioCryst制药股价,BioCryst制药股市,BioCryst制药股票价格,BioCryst制药股票交易,BioCryst制药股票购买,BioCryst制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioCryst制药(BCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioCryst制药(BCRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}